Two New FDA-Approved Treatments for RKD

TRUTAKNA® (atacicept) has been FDA approved for IgAN, click to learn more. FILSPARI® (sparsentan) has also been FDA approved for FSGS and more information is coming soon. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Rebecca Cook

Director, Strategic Operations

Rebecca "Birdie" Cook is NephCure’s Director of Strategic Operations. She rejoined the NephCure team in 2017 and hopped right back in! Rebecca grew up in Maryland and graduated from Bryn Mawr College in 2015 with a double major in Sociology and International Studies. While she used to work with our pharmaceutical partners, her role has shifted to be focused on internal operations and supporting NephCure's amazing staff! In her free time, she can be found cooking up a storm of vegetarian cuisine with local produce and taking pictures of her goofy tabby cat, Roland.

Boston, MA

Related News

NEWS

NephCure Celebrates C3G Awareness Day on September 25, 2026

NEWS

NephCure Specialist of the Month: Dr. Rupali Avasare

NEWS

Making History on Capitol Hill: Record Advocates Unite for NephCure’s Largest Hill Day Ever

NEWS

NephCure Specialist of the Month: Dr. Fahad Aziz

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.